1276.HK · HENGRUI PHARMA
Hong Kong · RS rating 27 · As of 2026-10-14
| Price | 46.50 HKD |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 76 / 20 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 17 / 31 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -10.1% |
| Distance from 52-week high | +49.6% |
| Market cap (USD) | $40.6B |